ATA Modified Risk of Structural Recurrence Classification – High Risk

Rodrigo Arrangoiz MS, MD, FACS, FSSO
  • A prospective multicenter study reported:
    • A significant improvement in:
      • Overall and disease-specific mortality, as well as disease-free survival:
        • In National Thyroid Cancer Cooperative Study Group (NTCTCSG):
          • Stage III and IV patients:
            • After statistical adjustment using multivariable and propensity stratified analyses
  • Furthermore, prospectively collected data from the SEER cancer registry:
    • Suggest that postsurgical RAI therapy is associated with improved overall survival:
      • In patients with PTC with distant metastases:
        • When distant metastases were combined with:
          • Age greater than 45 years
          • Tumor size greater than 2 cm
          • Positive lymph nodes at primary diagnosis
    • Data from the SEER database also suggest that overall survival:
      • In patients with FTC with distant metastases:
        • More than doubled in patients receiving postsurgical RAI treatment
  • Thus:
    • Routine postsurgical RAI treatment is re- commended in patients with ATA high-risk DTC

#Arrangoiz #CancerSurgeon #ThyroidSurgeon #ThyroidExpert #HeadandNeckSurgeon #RAI #ThryoidCancerTreatment #CASO #CenterforAdvancedSurgicalOncology

Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment